Versor Investments LP Novo Cure LTD Transaction History

Versor Investments LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$12.42 - $17.29 $155,250 - $216,125	12,500 New	12,500 $195,000
Q1 2023 May 05, 2023	BUY	$56.44 - $118.81 $657,356 - $1.38 Million	11,647 New	11,647 $700,000
Q3 2022 Oct 25, 2022	SELL	$67.99 - $89.57 $663,242 - $873,755	-9,755 Reduced 47.51%	10,776 $819,000
Q2 2022 Jul 27, 2022	BUY	$56.6 - $89.9 $1.16 Million - $1.85 Million	20,531 New	20,531 $1.43 Million

290

75.2M

1.81M

464K

Ticker NVCR
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 104,950,000
Market Cap $2.36B
Description
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...

Get notified when there are updates to the investment portfolio of Versor Investments LP, based on Form 13F filings with the SEC.

Stay updated on Versor Investments LP with notifications on news.